Biomay Obtains FDA Approval for Manufacturing of Cas9 Nuclease at Headquarters Site
29.4.2025 14:00:00 CEST | news aktuell GmbH | Press release
The company announced its successful approval by the U.S. Food and Drug Administration (FDA) for the manufacturing, testing and release of recombinant Cas9 nuclease from its headquarters site. Cas9 is an essential component of CRISPR-based gene editing therapies, including CASGEVY® (exagamglogene autotemcel) developed and launched by Vertex Pharmaceuticals.
Biomay's recent achievement refers to an inspection by the FDA's Center for Biologics Evaluation and Research (CBER) at Biomay's headquarters manufacturing site in Vienna, Seestadt in December 2024. No observation was found, and no Form FDA 483 was issued by the authority, allowing Biomay's headquarters site to supply Cas9 for the United States.
Biomay operates two independent cGMP manufacturing sites, a headquarters facility in Vienna Seestadt, and a second site in Vienna downtown. The authority’s approval of Biomay's headquarters site represents the company's second successful FDA inspection following the 2023 approval of Biomay's downtown facility. Biomay's headquarters site is a recently constructed, state-of-the-art biomanufacturing facility.
Biomay AG is a privately owned and fully integrated Contract Development and Manufacturing Organization (CDMO) based in Vienna, Austria. Founded in 1984, the expression of recombinant proteins by utilizing E. coli has been Biomay's business focus from the very beginning. Today, Biomay offers cGMP services for manufacturing of therapeutic proteins, plasmid DNA (pDNA) and messenger RNA (mRNA). The company's scope of CDMO services comprises process and analytical development, cell banking, cGMP manufacturing of drug substance and aseptic filling of drug product.
Contact:
Dr. Angela Neubauer, SVP Client Business; E-Mail: request@biomay.com / Biomay AG, Ada Lovelace-Str. 2, A-1220 Vienna, Austria www.biomay.com
Images
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Polarise secures further debt financing to expand its European AI cloud platform18.8.2026 11:47:20 CEST | Press release
Düsseldorf, 18. August 2026 – Polarise Holding GmbH (“Polarise”), a European provider of sovereign AI cloud solutions, has secured a debt financing partnership with SWI Stoneweg Icona Group (“SWI Group”) to accelerate the expansion of its European AI cloud platform. The financing of up to a high double-digit million-euro amount strengthens Polarise’s funding base for the continued execution of its growth strategy. As part of the new financing structure, Polarise and SWI Group have agreed to transition the previously announced majority equity investment agreement into a debt financing arrangement. Michel Boutouil, CEO of Polarise, said: “Our growth strategy is aimed at building Europe’s AI infrastructure of the future – with sustainable, highly efficient AI Factories and sovereign AI compute for businesses. We are executing this strategy with significant momentum and strong partners. Polarise develops and operates AI data centres – so-called AI Factories – in Germany and across Europe.
Central Council calls for prevention through education and awareness-raising3.8.2026 09:19:17 CEST | Press release
Commemorative event to mark the European Holocaust Remembrance Day for Sinti and Roma on 2 August 2026 in Auschwitz-Birkenau
CHRIST chooses fulfillmenttools and commercetools for a future-proof commerce architecture31.7.2026 12:47:56 CEST | Press release
Cologne – CHRIST Juweliere und Uhrmacher, one of Europe's most renowned jewelry retailers, is partnering with fulfillmenttools to transform the way it manages and orchestrates orders across its retail network. CHRIST is implementing the Agentic Order Management System (OMS) – as part of a broader transformation in which the retailer is building a modular, future-proof commerce architecture powered by commercetools Sphere, the autonomous commerce platform. The new system landscape spans stores and digital channels across Germany, Austria and the Netherlands. Breaking free from monolithic constraints For internationally operating retailers, the ability to respond flexibly and quickly to customer demand is a key success factor. This is especially true in the jewellery trade, which is shaped by specific requirements: high-value products, complex inventory structures, and customers who expect a first-class, seamless shopping experience at every touchpoint. CHRIST has built a strong operatio
Bikeleasing Group announces strategic investment in New Zealand’s leading bike leasing company Workride / Next strategic step in cross-continental expansion29.7.2026 14:18:02 CEST | Press release
The Bikeleasing Group announces strategic investment in Workride, New Zealand’s market leader for company bike leasing as an employee benefit. Around 2,000 New Zealand employers already use Workride’s offering. The investment extends the Bikeleasing Group’s international presence and marks its next cross-continental step in its growth trajectory.
Dr. Gunther von Hagens, Inventor of Plastination & Creator of BODY WORLDS, Has Passed Away27.7.2026 14:31:59 CEST | Press release
Heidelberg/Germany, July 27, 2026—It is with deep sadness that the family and the Institute for Plastination announce the passing of Dr. Gunther von Hagens, inventor of Plastination and creator of the BODY WORLDS exhibitions. He died on July 24, 2026, at the age of 81. Gunther von Hagens fundamentally transformed the field of anatomy. Through Plastination—the preservation technique he invented in 1977—he created an entirely new perspective of the human body for medical education, science and the general public. He made the complexity, vulnerability and beauty of the human body—previously reserved for the dissection room and anatomical textbooks –directly accessible to the wider public. Together with his wife and curator, Dr. Angelina Whalley, Gunther von Hagens created BODY WORLDS, one of the most successful exhibitions in the world. Since its debut, the exhibition has been visited by more than 58 million people. BODY WORLDS made anatomy publicly accessible, encouraged reflection on h
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom